Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Insights and Forecast to 2028

Report ID: 1549582 | Published Date: Jan 2025 | No. of Page: 90 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Riluzole
        1.2.3 Edaravone (Radicava)
        1.2.4 Other
    1.3 Market by Application
        1.3.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Drugs Store
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Perspective (2017-2028)
    2.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Growth Trends by Region
        2.2.1 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Amyotrophic Lateral Sclerosis (ALS) Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Dynamics
        2.3.1 Amyotrophic Lateral Sclerosis (ALS) Treatment Industry Trends
        2.3.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Drivers
        2.3.3 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Challenges
        2.3.4 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Amyotrophic Lateral Sclerosis (ALS) Treatment Players by Revenue
        3.1.1 Global Top Amyotrophic Lateral Sclerosis (ALS) Treatment Players by Revenue (2017-2022)
        3.1.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue
    3.4 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Concentration Ratio
        3.4.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue in 2021
    3.5 Amyotrophic Lateral Sclerosis (ALS) Treatment Key Players Head office and Area Served
    3.6 Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Product Solution and Service
    3.7 Date of Enter into Amyotrophic Lateral Sclerosis (ALS) Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Amyotrophic Lateral Sclerosis (ALS) Treatment Breakdown Data by Type
    4.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Forecasted Market Size by Type (2023-2028)
5 Amyotrophic Lateral Sclerosis (ALS) Treatment Breakdown Data by Application
    5.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size (2017-2028)
    6.2 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type
        6.2.1 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2017-2022)
        6.2.2 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2023-2028)
        6.2.3 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2017-2028)
    6.3 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application
        6.3.1 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2017-2022)
        6.3.2 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2023-2028)
        6.3.3 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2017-2028)
    6.4 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country
        6.4.1 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2017-2022)
        6.4.2 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size (2017-2028)
    7.2 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type
        7.2.1 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2017-2022)
        7.2.2 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2023-2028)
        7.2.3 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2017-2028)
    7.3 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application
        7.3.1 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2017-2022)
        7.3.2 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2023-2028)
        7.3.3 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2017-2028)
    7.4 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country
        7.4.1 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2017-2022)
        7.4.2 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type
        8.2.1 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2017-2028)
    8.3 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application
        8.3.1 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2017-2028)
    8.4 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Region
        8.4.1 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size (2017-2028)
    9.2 Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type
        9.2.1 Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2017-2022)
        9.2.2 Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2023-2028)
        9.2.3 Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2017-2028)
    9.3 Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application
        9.3.1 Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2017-2022)
        9.3.2 Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2023-2028)
        9.3.3 Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2017-2028)
    9.4 Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country
        9.4.1 Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2017-2022)
        9.4.2 Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type
        10.2.1 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type (2017-2028)
    10.3 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application
        10.3.1 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application (2017-2028)
    10.4 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country
        10.4.1 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Mitsubishi Tanabe Pharma
        11.1.1 Mitsubishi Tanabe Pharma Company Details
        11.1.2 Mitsubishi Tanabe Pharma Business Overview
        11.1.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Introduction
        11.1.4 Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2017-2022)
        11.1.5 Mitsubishi Tanabe Pharma Recent Developments
    11.2 Sanofi
        11.2.1 Sanofi Company Details
        11.2.2 Sanofi Business Overview
        11.2.3 Sanofi Amyotrophic Lateral Sclerosis (ALS) Treatment Introduction
        11.2.4 Sanofi Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2017-2022)
        11.2.5 Sanofi Recent Developments
    11.3 Mylan Pharma
        11.3.1 Mylan Pharma Company Details
        11.3.2 Mylan Pharma Business Overview
        11.3.3 Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Introduction
        11.3.4 Mylan Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2017-2022)
        11.3.5 Mylan Pharma Recent Developments
    11.4 Apotex
        11.4.1 Apotex Company Details
        11.4.2 Apotex Business Overview
        11.4.3 Apotex Amyotrophic Lateral Sclerosis (ALS) Treatment Introduction
        11.4.4 Apotex Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2017-2022)
        11.4.5 Apotex Recent Developments
    11.5 Glemark Generics
        11.5.1 Glemark Generics Company Details
        11.5.2 Glemark Generics Business Overview
        11.5.3 Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Treatment Introduction
        11.5.4 Glemark Generics Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2017-2022)
        11.5.5 Glemark Generics Recent Developments
    11.6 Covis Pharma
        11.6.1 Covis Pharma Company Details
        11.6.2 Covis Pharma Business Overview
        11.6.3 Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Introduction
        11.6.4 Covis Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2017-2022)
        11.6.5 Covis Pharma Recent Developments
    11.7 Sun Pharma
        11.7.1 Sun Pharma Company Details
        11.7.2 Sun Pharma Business Overview
        11.7.3 Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Introduction
        11.7.4 Sun Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2017-2022)
        11.7.5 Sun Pharma Recent Developments
    11.8 Lunan Pharma
        11.8.1 Lunan Pharma Company Details
        11.8.2 Lunan Pharma Business Overview
        11.8.3 Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Introduction
        11.8.4 Lunan Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2017-2022)
        11.8.5 Lunan Pharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Riluzole
    Table 3. Key Players of Edaravone (Radicava)
    Table 4. Key Players of Other
    Table 5. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Region (2017-2022)
    Table 9. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Region (2023-2028)
    Table 11. Amyotrophic Lateral Sclerosis (ALS) Treatment Market Trends
    Table 12. Amyotrophic Lateral Sclerosis (ALS) Treatment Market Drivers
    Table 13. Amyotrophic Lateral Sclerosis (ALS) Treatment Market Challenges
    Table 14. Amyotrophic Lateral Sclerosis (ALS) Treatment Market Restraints
    Table 15. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Share by Players (2017-2022)
    Table 17. Global Top Amyotrophic Lateral Sclerosis (ALS) Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment as of 2021)
    Table 18. Ranking of Global Top Amyotrophic Lateral Sclerosis (ALS) Treatment Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Amyotrophic Lateral Sclerosis (ALS) Treatment Product Solution and Service
    Table 22. Date of Enter into Amyotrophic Lateral Sclerosis (ALS) Treatment Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Type (2017-2022)
    Table 26. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Type (2023-2028)
    Table 28. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Share by Application (2017-2022)
    Table 30. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Share by Application (2023-2028)
    Table 32. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 62. Mitsubishi Tanabe Pharma Company Details
    Table 63. Mitsubishi Tanabe Pharma Business Overview
    Table 64. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Product
    Table 65. Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2017-2022) & (US$ Million)
    Table 66. Mitsubishi Tanabe Pharma Recent Developments
    Table 67. Sanofi Company Details
    Table 68. Sanofi Business Overview
    Table 69. Sanofi Amyotrophic Lateral Sclerosis (ALS) Treatment Product
    Table 70. Sanofi Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2017-2022) & (US$ Million)
    Table 71. Sanofi Recent Developments
    Table 72. Mylan Pharma Company Details
    Table 73. Mylan Pharma Business Overview
    Table 74. Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Product
    Table 75. Mylan Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2017-2022) & (US$ Million)
    Table 76. Mylan Pharma Recent Developments
    Table 77. Apotex Company Details
    Table 78. Apotex Business Overview
    Table 79. Apotex Amyotrophic Lateral Sclerosis (ALS) Treatment Product
    Table 80. Apotex Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2017-2022) & (US$ Million)
    Table 81. Apotex Recent Developments
    Table 82. Glemark Generics Company Details
    Table 83. Glemark Generics Business Overview
    Table 84. Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Treatment Product
    Table 85. Glemark Generics Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2017-2022) & (US$ Million)
    Table 86. Glemark Generics Recent Developments
    Table 87. Covis Pharma Company Details
    Table 88. Covis Pharma Business Overview
    Table 89. Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Product
    Table 90. Covis Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2017-2022) & (US$ Million)
    Table 91. Covis Pharma Recent Developments
    Table 92. Sun Pharma Company Details
    Table 93. Sun Pharma Business Overview
    Table 94. Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Product
    Table 95. Sun Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2017-2022) & (US$ Million)
    Table 96. Sun Pharma Recent Developments
    Table 97. Lunan Pharma Company Details
    Table 98. Lunan Pharma Business Overview
    Table 99. Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Product
    Table 100. Lunan Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2017-2022) & (US$ Million)
    Table 101. Lunan Pharma Recent Developments
    Table 102. Research Programs/Design for This Report
    Table 103. Key Data Information from Secondary Sources
    Table 104. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Riluzole Features
    Figure 3. Edaravone (Radicava) Features
    Figure 4. Other Features
    Figure 5. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application: 2021 VS 2028
    Figure 6. Hospital Case Studies
    Figure 7. Drugs Store Case Studies
    Figure 8. Other Case Studies
    Figure 9. Amyotrophic Lateral Sclerosis (ALS) Treatment Report Years Considered
    Figure 10. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Region: 2021 VS 2028
    Figure 13. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Players in 2021
    Figure 14. Global Top Amyotrophic Lateral Sclerosis (ALS) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue in 2021
    Figure 16. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 17. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Type (2017-2028)
    Figure 18. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Application (2017-2028)
    Figure 19. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Share by Country (2017-2028)
    Figure 20. United States Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Type (2017-2028)
    Figure 24. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Application (2017-2028)
    Figure 25. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Share by Country (2017-2028)
    Figure 26. Germany Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 33. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Type (2017-2028)
    Figure 34. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Application (2017-2028)
    Figure 35. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Share by Region (2017-2028)
    Figure 36. China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. South Korea Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Australia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 43. Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Type (2017-2028)
    Figure 44. Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Application (2017-2028)
    Figure 45. Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Share by Country (2017-2028)
    Figure 46. Mexico Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Brazil Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 49. Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Type (2017-2028)
    Figure 50. Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Market Share by Application (2017-2028)
    Figure 51. Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Share by Country (2017-2028)
    Figure 52. Turkey Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. UAE Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Mitsubishi Tanabe Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2017-2022)
    Figure 56. Sanofi Revenue Growth Rate in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2017-2022)
    Figure 57. Mylan Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2017-2022)
    Figure 58. Apotex Revenue Growth Rate in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2017-2022)
    Figure 59. Glemark Generics Revenue Growth Rate in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2017-2022)
    Figure 60. Covis Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2017-2022)
    Figure 61. Sun Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2017-2022)
    Figure 62. Lunan Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2017-2022)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Mitsubishi Tanabe Pharma
Sanofi
Mylan Pharma
Apotex
Glemark Generics
Covis Pharma
Sun Pharma
Lunan Pharma
Frequently Asked Questions
Amyotrophic Lateral Sclerosis (ALS) Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Amyotrophic Lateral Sclerosis (ALS) Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Amyotrophic Lateral Sclerosis (ALS) Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Anechoic Chambers

Anechoic Chambers market is segmented by Type and by Application. Players, stakeholders, and othe ... Read More

Antacid

Antacid market is segmented by Type and by Application. Players, stakeholders, and other particip ... Read More

Antiscalant

Antiscalant market is segmented by Type and by Application. Players, stakeholders, and other part ... Read More

Aptamers

Aptamers market is segmented by players, region (country), by Type and by Application. Players, s ... Read More